WRMT World Media & Technology Corp Going Big on Non Invasive Blood Glucose Technology

by Admin
Comments are off for this post.


The diabetes market is huge. One in eight people in the United States have diabetes or are pre-diabetic.  This market has a great need for blood glucose monitors.  The potential to have a non-invasive blood glucose monitor is huge. The medical expenses spent on diabetes and diabetes related medicine is dramatic. As the press release from WMRT indicates the Helo LX will be a winner:  http://oracledispatch.com/2017/01/15/world-media-technology-corp-otcmktswrmt-goes-orbit-glucose-bet/

The press release says:

“its research activity generating non-invasive, continuous blood glucose estimates has been found to be sufficiently accurate to allow WRMT to proceed to full integration of the algorithm in the Helo platform so WRMT can offer blood glucose estimation as a service in Q4’17 to Helo wearers who choose to pay an initial set-up fee and an ongoing monthly charge.”

That appears to set up a push toward major top line growth later this year. According to the International Diabetes Federation, 415 million people worldwide (1 in 11 people) have diabetes consuming 12% of global health expenditure ($673B) in 2015. The American Diabetes Association advises that in the US, nearly 30 million (1 in 8) people have diabetes and $1 in $5 health care dollars is spent caring for people with diabetes.  Americans with diagnosed diabetes incur average medical expenditures of about $13,700 per year, of which about $7,900 is attributed to diabetes.”

To learn more about the Helo LX and its potential simply go to Helo LX

Share this article

Comments are closed.

%d bloggers like this: